PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA

Bibliographic Details
Main Authors: B. Kahl, J. Cohen, R. Pillai, V. Jayaprakash, C. Wang, M. Hahka-Kemppinen, M. Kania, P. Zinzani
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7
_version_ 1797281299611779072
author B. Kahl
J. Cohen
R. Pillai
V. Jayaprakash
C. Wang
M. Hahka-Kemppinen
M. Kania
P. Zinzani
author_facet B. Kahl
J. Cohen
R. Pillai
V. Jayaprakash
C. Wang
M. Hahka-Kemppinen
M. Kania
P. Zinzani
author_sort B. Kahl
collection DOAJ
first_indexed 2024-03-07T16:55:33Z
format Article
id doaj.art-f72b261d0f444718918a6bd8f18b583e
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:55:33Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-f72b261d0f444718918a6bd8f18b583e2024-03-03T04:28:11ZengWileyHemaSphere2572-92412022-06-0161760176110.1097/01.HS9.0000850372.60201.c7202206003-01760PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMAB. Kahl0J. Cohen1R. Pillai2V. Jayaprakash3C. Wang4M. Hahka-Kemppinen5M. Kania6P. Zinzani71 Washington University School of Medicine, St Loius2 Emory University School of Medicine, Atlanta3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America3 HUTCHMED International Corporation, Florham Park, United States of America4 University of Bologna Institute of Hematology, Bologna, Italyhttp://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7
spellingShingle B. Kahl
J. Cohen
R. Pillai
V. Jayaprakash
C. Wang
M. Hahka-Kemppinen
M. Kania
P. Zinzani
PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
HemaSphere
title PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_full PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_fullStr PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_full_unstemmed PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_short PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_sort pb1880 a multicenter phase 1 study evaluating the safety and tolerability of hmpl 760 in patients with previously treated chronic lymphocytic leukemia small lymphocytic lymphoma or other non hodgkin lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000850372.60201.c7
work_keys_str_mv AT bkahl pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT jcohen pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT rpillai pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT vjayaprakash pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT cwang pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT mhahkakemppinen pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT mkania pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT pzinzani pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma